Inari Deferred Long Term Liab from 2010 to 2024
| NARI Stock | USD 49.28 1.01 2.01% |
Deferred Long Term Liabilities | First Reported 2010-12-31 | Previous Quarter 47.7 K | Current Value 45.3 K | Quarterly Volatility 642.3 K |
Check Inari Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inari Medical's main balance sheet or income statement drivers, such as Net Interest Income of 16.2 M, Interest Income of 16.4 M or Depreciation And Amortization of 11.3 M, as well as many indicators such as Price To Sales Ratio of 7.09, Dividend Yield of 0.0 or PTB Ratio of 8.32. Inari financial statements analysis is a perfect complement when working with Inari Medical Valuation or Volatility modules.
Inari | Deferred Long Term Liab |
Latest Inari Medical's Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of Inari Medical over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Inari Medical's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inari Medical's overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
Inari Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 1,034,201 | |
| Geometric Mean | 610,080 | |
| Coefficient Of Variation | 62.11 | |
| Mean Deviation | 579,732 | |
| Median | 1,469,000 | |
| Standard Deviation | 642,334 | |
| Sample Variance | 412.6B | |
| Range | 1.4M | |
| R-Value | (0.83) | |
| Mean Square Error | 135.4B | |
| R-Squared | 0.70 | |
| Significance | 0.0001 | |
| Slope | (119,756) | |
| Total Sum of Squares | 5.8T |
Inari Deferred Long Term Liab History
About Inari Medical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Inari Medical income statement, its balance sheet, and the statement of cash flows. Inari Medical investors use historical funamental indicators, such as Inari Medical's Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Although Inari Medical investors may use each financial statement separately, they are all related. The changes in Inari Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Inari Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Inari Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Inari Medical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 47.7 K | 45.3 K |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Inari Stock
When determining whether Inari Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inari Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inari Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inari Medical Stock:Check out the analysis of Inari Medical Correlation against competitors. For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.84) | Earnings Share (0.41) | Revenue Per Share 9.045 | Quarterly Revenue Growth 0.233 | Return On Assets (0.01) |
The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inari Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.